Clinical and experimental investigations on the effect of cytostatic drugs in psoriasis.
D000630:Aminopterin / Q000627:therapeutic use; D000961:Antilymphocyte Serum / Q000627:therapeutic use; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D001379:Azathioprine / Q000627:therapeutic use; D003520:Cyclophosphamide / Q000627:therapeutic use; D003609:Dactinomycin / Q000627:therapeutic use; D003630:Daunorubicin / Q000627:therapeutic use; D005472:Fluorouracil / Q000627:therapeutic use; D005971:Glutamates; D012696:Glycine Hydroxymethyltransferase / Q000378:metabolism; D006801:Humans; D006918:Hydroxyurea / Q000627:therapeutic use; D008466:Mechlorethamine / Q000627:therapeutic use; D008727:Methotrexate / Q000627:therapeutic use; D011565:Psoriasis / Q000188:drug therapy* / Q000201:enzymology / Q000276:immunology; D013762:Tetrahydrofolate Dehydrogenase / Q000378:metabolism; D013763:Tetrahydrofolates; D014166:Transferases / Q000378:metabolism; D014747:Vinblastine / Q000627:therapeutic use
D000961:Antilymphocyte Serum; D000970:Antineoplastic Agents; D005971:Glutamates; D013763:Tetrahydrofolates; D003609:Dactinomycin; D008466:Mechlorethamine; D014747:Vinblastine; D003520:Cyclophosphamide; D013762:Tetrahydrofolate Dehydrogenase; D014166:Transferases; D012696:Glycine Hydroxymethyltransferase; D000630:Aminopterin; D001379:Azathioprine; D005472:Fluorouracil; D006918:Hydroxyurea; D008727:Methotrexate; D003630:Daunorubicin